Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group
about
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell linesPatterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeHigh fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivoPhase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.RESEARCH ADVANCES IN NEUROBLASTOMA IMMUNOTHERAPY.Optimizing drug development of anti-cancer drugs in children using modelling and simulation.Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.Topotecan and cyclophosphamide in adults with relapsed sarcoma.Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma.Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.
P2860
Q28535586-F01A4160-69EB-4686-B42B-9CDA117C463EQ33396263-4613AD75-DBBA-440F-B883-10644588CE9DQ33998443-85894305-CEE5-4D44-884B-C0F55E2170D6Q35647150-3ADF8A2D-73AD-44E0-B2E5-535DF6122630Q36511158-21E35B4C-F27B-43E3-A52C-494BB0BD1BE9Q36652629-804524A7-EE04-4711-AD98-52C74CC048F6Q36776358-EC2A7DEA-3716-4F55-A4C9-6246EB5A997EQ36987975-AE5420E3-91B7-4466-857C-AEE50C82A6B5Q38262916-C3484343-857D-4A02-9625-66D8D60708ABQ40278945-FA48C406-5629-487B-AD1E-70E0E41AF6D3Q43150200-ED274556-E669-4DE7-ADFF-1265B5E28343Q44028238-93366C4A-B974-40DA-90E2-9841297E142EQ50948139-237295BA-AC78-40CC-A240-DB6A0A919602
P2860
Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population pharmacokinetics of ...... the Children's Oncology Group
@en
Population pharmacokinetics of ...... the Children's Oncology Group.
@nl
type
label
Population pharmacokinetics of ...... the Children's Oncology Group
@en
Population pharmacokinetics of ...... the Children's Oncology Group.
@nl
prefLabel
Population pharmacokinetics of ...... the Children's Oncology Group
@en
Population pharmacokinetics of ...... the Children's Oncology Group.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... the Children's Oncology Group
@en
P2093
Celeste Oglesby
David H Salinger
David K Blough
Julie R Park
Paolo Vicini
P2860
P304
P356
10.1177/0091270008325928
P577
2008-10-16T00:00:00Z